Drug-eluting stents (DES) have been available commercially in the UK for over three years. The National Institute for Clinical Excellence (NICE) produced a technology appraisal in October 2003 and that initial review is about to be updated. Well, has this technology delivered on its promise? Have we embraced it too quickly or is 100% DES usage around the corner?
Are drug-eluting stents living up to the hype?
July 2005Br J Cardiol (Acute Interv) Cardiol 2005;12:AIC 42–AIC 44 Leave a commentClick any image to enlarge
